Skip to main content
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology logoLink to American Journal of Physiology - Regulatory, Integrative and Comparative Physiology
. 2015 Oct 7;309(9):R1078–R1081. doi: 10.1152/ajpregu.00156.2015

Direct renal effects of a fructose-enriched diet: interaction with high salt intake

Gustavo R Ares 1, Pablo A Ortiz 1,2,
PMCID: PMC4666953  PMID: 26447210

Abstract

Consumption of fructose has increased during the last 50 years. Excessive fructose consumption has a detrimental effect on mammalian health but the mechanisms remain unclear. In humans, a direct relationship exists between dietary intake of added sugars and increased risk for cardiovascular disease mortality (52). While the causes for this are unclear, we recently showed that fructose provided in the drinking water induces a salt-dependent increase in blood pressure in Sprague-Dawley rats in a matter of days (6). However, little is known about the effects of fructose in renal salt handling and whether combined intake of high fructose and salt can lead to salt-sensitive hypertension before the development of metabolic abnormalities. The long-term (more than 4 wk) adverse effects of fructose intake on renal function are not just due to fructose but are also secondary to alterations in metabolism which may have an impact on renal function. This minireview focuses on the acute effect of fructose intake and its effect on salt regulation, as they affect blood pressure.

Keywords: fructose, renal function, NKCC2, salt sensitivity


in the late 1960s, refining, isomerization, and separation technologies made possible the production from corn starch of high-fructose syrup (32). Since then, consumption of fructose in the human diet increased has dramatically reaching a maximum level between 2005 and 2010, which has been maintained during the last 10 years (16, 49). One of the principal sources of added sugars (fructose and glucose) in our diet, is sugar-sweetened beverages. The effect of fructose on glucose and lipid metabolism is dependent on the dose and duration of consumption (9). For instance, metabolic syndrome (defined in humans as a large waistline, high triglycerides, high blood glucose, low high-density lipoproteins levels, and high blood pressure) can be induced in rodents by feeding concentrations of fructose as low as 20% for 8 wk or more (43), with metabolic alterations (including insulin resistance) usually starting after 6 wk (Table 1). Independently from the amount of fructose, most studies report an increase in plasma uric acid, leptin, glucose, insulin, cholesterol, and triglycerides starting after 6–8 wk on 10–60% fructose intake (14, 20, 22, 23, 34, 43). However, most studies do not directly report the percentage of caloric intake consumed from fructose since varying concentrations in the drinking water result in differences in volume intake. Thus the majority of data in rodents support a detrimental effect on chronic fructose consumption; howeve, new evidence indicates that important renal physiological parameters are affected by acute fructose consumption. Fructose intake induces signaling in the gut and liver within minutes after consumption and during its transport. However, little is known about the effects of acute (hours) and chronic (weeks-months) fructose consumption on renal NaCl reabsorption and its potential role in blood pressure (BP) regulation. To understand these mechanisms it would require an approach that includes a comparison between a time-dependent effect of fructose and glucose on renal physiological changes and blood pressure regulation while varying salt content in the diet.

Table 1.

Effects of fructose on renal function, blood pressure, and metabolic status

Fructose Concentration Salt Species Duration of Treatment Effect/Conclusion Reference
In food
    40% 3% Rats 2 Weeks Salt-sensitive hypertension 35
    60% Normal Rats 10 Weeks Metabolic syndrome 34
    60% Normal Rats 8 Weeks Metabolic Syndrome/renal hypertrophy, glomerular hypertension, cortical vasoconstriction 43
    60% Normal Rats 12 Days ↑ Blood pressure and induces Salt-sensitivity 41
    60% Normal Rats 6 Weeks ↓Creatinine clearance, induces chronic kidney disease 14
    60% Normal Rats 12 Weeks Metabolic Syndrome,↑ Blood pressure 45
    65% Normal Mice 12 Weeks No change in blood pressure, ↓ NKCC2 expression, and ↓aquaporin-2 44, 46
    65% Normal Rats 2 Weeks ↑ Blood pressure, Hyperinsulinemia, Hypertriglyceridemia 20
In drinking water
    10% Normal Rats Within 7 Days ↑ Blood pressure 9
    10% 4% Mice 3 Weeks Salt-sensitive hypertension, ↑Insulin 19
    11% Normal Humans 1 Week Salt is a major determinant of fluid and sugar-sweetened drink consumption during childhood 18
    15% Normal Humans 1–2 Day ↓Insulin, ↓glucose; ↓Ghrelin; ↑triglycerides 50
    20% 8% Rats 1 Week Salt-sensitive hypertension 6

Hypertension, Fructose, and Salt Intake

Hypertension is a complex polygenic disorder that is often influenced by dietary factors. Salt handling by the kidney is essential for long-term blood pressure control. The relationship between high fructose consumption and human hypertension is the subject of debate. Some clinical studies have shown no association with fructose intake and hypertension (8, 15), whereas others have shown a positive correlation (4, 5, 9). In addition to high fructose, most people consume excess salt, fat, and protein in their diets. It is not clear how these secondary factors affect the response of elevated fructose intake. A single study in humans examined the combined effect of fructose and salt intake (5) and showed a positive correlation between fructose consumption and hypertension, which was enhanced by high salt intake. In most rat studies, high fructose intake (40–60%) for prolonged periods of time (more than 2 mo) causes hypertension, insulin resistance, and hyperuricemia (14, 20, 34, 43, 45). However, the amount of fructose that humans consume is generally lower than 40% of the total daily caloric intake (20, 31). In the United States, the upper quartile of the adult population (up to 30 million Americans) consume 20–40% of their caloric intake from added sugars, with half of those calories (10–20%) coming from fructose. However, in most studies, feeding rats 10–20% of caloric intake from fructose does not increase BP before the development of metabolic alterations (6, 19). This observation suggests that high fructose intake may not cause hypertension during normal salt intake despite inducing deleterious signaling in the kidney and other organs. Yet it is unclear whether a fructose-enriched diet induces a salt-dependent increase in BP because the acute and chronic effects of fructose on nephron salt handling have been poorly studied. Recently, Cabral et al. (6) showed that in rats fed fructose (20% in drinking water) plus high salt induced a salt-sensitive increase in BP, whereas fructose alone did not. These data are in agreements with a 1994 study conducted by Reed et al. (41) showing that fructose (10–20% in drinking water) induced salt-sensitive hypertension in other strains of salt-resistant rats. Thus it is possible to speculate that enhanced fructose intake prevents adequate NaCl handling by the kidney in rodents and humans.

Effect of Fructose in Nephron Ion Transport

There are large differences between glucose and fructose metabolism as well as their handling by the kidney. First, glucose and fructose are not metabolized equally by the liver, and the transporters and enzymes involved are different (13, 17, 29, 49). Second, in humans and rodents on normal diets, baseline plasma glucose is ∼5 mM, whereas plasma fructose is ∼0.05 to 0.25 mM (30, 39). Third, glucose filtered through the glomeruli is completely reabsorbed in the proximal tubule by sodium-glucose-linked transporters SGLT1 and SGLT2,whereas fructose is not, and considerable amounts of fructose can be measured in human and rodent urine after an oral fructose load (24, 27). Part of the filtered fructose is reabsorbed by the proximal tubule via the fructose transporters SGLT5, GLUT5, and GLUT2 and metabolized, whereas approximately half of filtered fructose is excreted in urine (10, 31, 37, 45, 48). Since fructose is not completely reabsorbed in the proximal tubule, it moves along the nephron and gets concentrated in the forming urine (27). It is not known how concentrated fructose could be in the distal nephron segments since this has not been measured.

Few investigators have studied the effect of fructose on renal salt reabsorption. Queiroz-Leite et al. (40) studied the acute effect of fructose in proximal tubule bicarbonate reabsorption using in vivo micropunture. They reported that 2–3 mM luminal fructose increased bicarbonate reabsorption indicative of a stimulation of NaCl reabsorption, whereas glucose did not affect transport. This effect seemed to be secondary to enhanced sodium-hydrogen exchanger 3 (NHE3) activity because 3 mM fructose increased NHE3 activity in the proximal tubule cell line. Recently, Cabral et al. (6) found that 20–30 min incubation with 3 or 5 mM fructose in the luminal solution enhanced NHE3 activity in isolated perfused rat proximal tubules. A 5 mM concentration of fructose also enhanced the stimulatory effect of ANG II on NHE3 activity. These data suggest that an acute increase in filtered fructose, as it occurs after ingestion of fructose, may increase proximal tubule NaCl reabsorption directly or by enhancing the stimulatory effect of ANG II. The chronic effect of fructose consumption in proximal tubule NaCl reabsorption has not been studied to our knowledge. Also, the acute or chronic effects of fructose on the thick ascending limb, distal tubule, or collecting ducts ion transport have not been studied. We recently began studies to address the effect of fructose on thick ascending limb NaCl transport. Our data (Ares GR, Ortiz PA; unpublished observations) suggest that acute treatment with 5 mM fructose (but not 5 mM glucose) increases NaCl transport by rat thick ascending limbs. This acute effect may be related to activation of the apical Na-K-2Cl cotransporter NKCC2 because fructose, but not glucose, enhanced apical surface NKCC2 levels (unpublished observations; Ares, GR, Ortiz, PA). Collectively, these data suggest that fructose per se can rapidly enhance proximal tubule and thick ascending limb NaCl transport. This effect could be related to the salt sensitivity observed when rats are fed high-fructose and high-salt diets. However, little is known about the effect of fructose in the kidney and whether the mechanism for its action is due to fructose activating signaling along the nephron.

In humans, plasma fructose increases from 0.2 to 1 mM after postprandial fructose (24, 27). In the gut and liver, fructose activates signaling after it is transported into the cell by GLUT2 transporters (11, 31). In the kidney, filtered fructose reaches not just the proximal tubule (where it is reabsorbed) but also distal parts of the nephron via the forming urine (27). To our knowledge, the effect of fructose in the distal nephron segments is unclear. While these questions have not been explored, it is clear that we cannot extrapolate concepts learned from hyperglycemic-induced signaling in the distal nephron because glucose-induced signaling is likely to be completely different from fructose-induced signaling. Concentrations of glucose high enough to reach the distal nephron are only found in diabetic patients or animal models of diabetes, whereas a relevant concentration of fructose along the nephron occur every time after ingestion of fructose-sweetened beverages. Given that most people consume high fructose- and high salt-containing diets, we think that the interaction between these dietary factors is an important area of investigation that has been overlooked.

Fructose consumption has also been linked to obesity (12, 49) based on studies showing that fructose increases food intake in rodents when compared with glucose (7). Other studies indicated that both fructose and glucose increase appetite and/or decreases satiety (33, 36). Fructose consumption affects de novo lipogenesis (42) and ectopic lipid disposition in humans (26, 47) and rodents (25). Taken together, these studies suggest that in rats, sugar (both fructose and glucose) provide calories to the diet without providing a negative feedback to decrease appetite thereby leading to weight gain. However, whether fructose induces obesity and weight gain in humans is not so clear. This is based on the nature of the studies, in which detrimental metabolic effects have been observed after excessive isolated fructose intakes in human subjects (21, 38). On the other hand, food disappearance data indicate that fructose consumption from added sugars has increased over time and paralleled the increase in obesity (23, 49). However, studies performed under isocaloric exchange conditions in humans testing the effect of fructose on weight gain showed there was no difference compared with other sugars (2, 28). While it is known that fructose consumption leads to lipid accumulation in the liver (3, 51), whether fructose induces obesity and weight gain (when compared with glucose for instance) needs further investigation.

Perspectives and Significance

Hypertension is now the leading cause of “loss of health” worldwide. Genetic background and dietary factors (such as fructose intake) influences the response to salt in humans and may contribute to salt-sensitive hypertension. However, little is known about the interaction and renal effects of high fructose and high salt intake in humans or animal models. Thus understanding the effect of fructose (without the confounding effect of other metabolic changes) on renal function and blood pressure regulation may help to understand the real effect of the added sugars in our diet and may help justify a decrease in their intake in humans.

REFERENCES

  • 1.Ares GR, Ortiz PA. Fructose potently stimulates NKCC2 trafficking in rat thick ascending limbs. Council Of High Blood Pressure (Abstract). Hypertension 62: A639, 2013. [Google Scholar]
  • 2.Beck-Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr 33: 273–278, 1980. [DOI] [PubMed] [Google Scholar]
  • 3.Bray GA, Popkin BM. Calorie-sweetened beverages and fructose: what have we learned 10 years later. Pediatr Obes 8: 242–248, 2013. [DOI] [PubMed] [Google Scholar]
  • 4.Brown CM, Dulloo AG, Yepuri G, Montani JP. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 294: R730–R737, 2008. [DOI] [PubMed] [Google Scholar]
  • 5.Brown IJ, Stamler J, Van HL, Robertson CE, Chan Q, Dyer AR, Huang CC, Rodriguez BL, Zhao L, Daviglus ML, Ueshima H, Elliott P. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension 57: 695–701, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cabral PD, Hong NJ, Hye Khan MA, Ortiz PA, Beierwaltes WH, Imig JD, Garvin JL. Fructose stimulates Na/H exchange activity and sensitizes the proximal tubule to angiotensin II. Hypertension 63: e68–e73, 2014. [DOI] [PubMed] [Google Scholar]
  • 7.Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD. Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc Natl Acad Sci USA 105: 16871–16875, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med 27: 1127–1134, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dai S, McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods 33: 101–107, 1995. [DOI] [PubMed] [Google Scholar]
  • 10.Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 295: E227–E237, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Douard V, Ferraris RP. The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol 591: 401–414, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Drewnowski A, Bellisle F. Liquid calories, sugar, and body weight. Am J Clin Nutr 85: 651–661, 2007. [DOI] [PubMed] [Google Scholar]
  • 13.Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76: 911–922, 2002. [DOI] [PubMed] [Google Scholar]
  • 14.Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, Sautin YY, Johnson RJ, Nakagawa T. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 293: F1256–F1261, 2007. [DOI] [PubMed] [Google Scholar]
  • 15.Ha V, Sievenpiper JL, de Souza RJ, Chiavaroli L, Wang DD, Cozma AI, Mirrahimi A, Yu ME, Carleton AJ, Dibuono M, Jenkins AL, Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 59: 787–795, 2012. [DOI] [PubMed] [Google Scholar]
  • 16.Haley S. Jane Reed, Biing-Hwan Lin, Annetta Cook. Sweetener sonsumption in the United States. In: Electronic Outlook Report from the Economic Research Service. Washington DC: USDA; http://www.ers.usda.gov/media/326278/sss24301_002.pdf, 2015. [Google Scholar]
  • 17.Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63: 133–157, 2005. [DOI] [PubMed] [Google Scholar]
  • 18.He FJ, Marrero NM, MacGregor GA. Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension 51: 629–634, 2008. [DOI] [PubMed] [Google Scholar]
  • 19.Huang DY, Boini KM, Friedrich B, Metzger M, Just L, Osswald H, Wulff P, Kuhl D, Vallon V, Lang F. Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1. Am J Physiol Regul Integr Comp Physiol 290: R935–R944, 2006. [DOI] [PubMed] [Google Scholar]
  • 20.Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512–516, 1987. [DOI] [PubMed] [Google Scholar]
  • 21.Johnson RJ, Lanaspa MA, Roncal-Jimenez C, Sanchez-Lozada LG. Effects of excessive fructose intake on health. Ann Intern Med 156: 905–906, 2012. [DOI] [PubMed] [Google Scholar]
  • 22.Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol 21: 2036–2039, 2010. [DOI] [PubMed] [Google Scholar]
  • 23.Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86: 899–906, 2007. [DOI] [PubMed] [Google Scholar]
  • 24.Kawasaki T, Akanuma H, Yamanouchi T. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care 25: 353–357, 2002. [DOI] [PubMed] [Google Scholar]
  • 25.Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139: 2067–2071, 2009. [DOI] [PubMed] [Google Scholar]
  • 26.Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 89: 1760–1765, 2009. [DOI] [PubMed] [Google Scholar]
  • 27.Le MT, Frye RF, Rivard CJ, Cheng J, McFann KK, Segal MS, Johnson RJ, Johnson JA. Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism 61: 641–651, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Livesey G. Fructose ingestion: dose-dependent responses in health research. J Nutr 139: 1246S–1252S, 2009. [DOI] [PubMed] [Google Scholar]
  • 29.Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 110: 1307–1321, 2010. [DOI] [PubMed] [Google Scholar]
  • 30.Madero M, Perez-Pozo SE, Jalal D, Johnson RJ, Sanchez-Lozada LG. Dietary fructose and hypertension. Curr Hypertens Rep 13: 29–35, 2011. [DOI] [PubMed] [Google Scholar]
  • 31.Manolescu AR, Witkowska K, Kinnaird A, Cessford T, Cheeseman C. Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 22: 234–240, 2007. [DOI] [PubMed] [Google Scholar]
  • 32.Marshall RO, Kooi ER. Enzymatic conversion of d-glucose to d-fructose. Science 125: 648–649, 1957. [DOI] [PubMed] [Google Scholar]
  • 33.Melanson KJ, Zukley L, Lowndes J, Nguyen V, Angelopoulos TJ, Rippe JM. Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition 23: 103–112, 2007. [DOI] [PubMed] [Google Scholar]
  • 34.Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625–F631, 2006. [DOI] [PubMed] [Google Scholar]
  • 35.Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K. Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 40: 190–194, 2002. [DOI] [PubMed] [Google Scholar]
  • 36.Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309: 63–70, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Park SH, Lee YJ, Lim MJ, Kim EJ, Lee JH, Han HJ. High glucose inhibits fructose uptake in renal proximal tubule cells: involvement of cAMP, PLC/PKC, p44/42 MAPK, and cPLA2. J Cell Physiol 200: 407–416, 2004. [DOI] [PubMed] [Google Scholar]
  • 38.Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 34: 454–461, 2010. [DOI] [PubMed] [Google Scholar]
  • 39.Petersen A, Kappler F, Szwergold BS, Brown TR. Fructose metabolism in the human erythrocyte. Phosphorylation to fructose 3-phosphate. Biochem J 284: 363–366, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Queiroz-Leite GD, Crajoinas RO, Neri EA, Bezerra CN, Girardi AC, Reboucas NA, Malnic G. Fructose acutely stimulates NHE3 activity in kidney proximal tubule. Kidney Blood Press Res 36: 320–334, 2012. [DOI] [PubMed] [Google Scholar]
  • 41.Reed MJ, Ho H, Donnelly R, Reaven GM. Salt-sensitive and carbohydrate-sensitive rodent hypertension: evidence of strain differences. Blood Press 3: 197–201, 1994. [DOI] [PubMed] [Google Scholar]
  • 42.Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 22: 60–65, 2011. [DOI] [PubMed] [Google Scholar]
  • 43.Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, vila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292: F423–F429, 2007. [DOI] [PubMed] [Google Scholar]
  • 44.Sharma N, Li L, Ecelbarger CM. Sex differences in renal and metabolic responses to a high-fructose diet in mice. Am J Physiol Renal Physiol 308: F400–F410, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Singh AK, Amlal H, Haas PJ, Dringenberg U, Fussell S, Barone SL, Engelhardt R, Zuo J, Seidler U, Soleimani M. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 74: 438–447, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Song J, Hu X, Shi M, Knepper MA, Ecelbarger CA. Effects of dietary fat, NaCl, and fructose on renal sodium and water transporter abundances and systemic blood pressure. Am J Physiol Renal Physiol 287: F1204–F1212, 2004. [DOI] [PubMed] [Google Scholar]
  • 47.Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322–1334, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sugawara-Yokoo M, Suzuki T, Matsuzaki T, Naruse T, Takata K. Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney Int 56: 1022–1028, 1999. [DOI] [PubMed] [Google Scholar]
  • 49.Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90: 23–46, 2010. [DOI] [PubMed] [Google Scholar]
  • 50.Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89: 2963–2972, 2004. [DOI] [PubMed] [Google Scholar]
  • 51.Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 57: 2525–2531, 2013. [DOI] [PubMed] [Google Scholar]
  • 52.Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 10, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Regulatory, Integrative and Comparative Physiology are provided here courtesy of American Physiological Society

RESOURCES